Covered recipient · General Payments record
DORISBEL MATOS-LIZARDO
Allopathic & Osteopathic Physicians General Practice
General Payments · PY2022–2024
$491.16
- Reported across 20 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $303.47 | 14 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $94.93 | 4 |
| Lilly USA, LLC | $43.13 | 2 |
| Amgen Inc. | $42.18 | 2 |
| Novo Nordisk AS | $31.19 | 2 |
| PFIZER INC. | $26.37 | 1 |
| DEXCOM, INC. | $25.30 | 1 |
| Phadia US Inc. | $23.57 | 1 |
| Xeris Pharmaceuticals, Inc. | $16.80 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (14)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $22.35 | 01/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104984559 | CMS |
| ABBVIE INC. | $21.75 | 02/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104984561 | CMS |
| ABBVIE INC. | $31.18 | 04/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104984563 | CMS |
| ABBVIE INC. | $19.65 | 06/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104984565 | CMS |
| Amgen Inc. | $25.33 | 03/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117321226 | CMS |
| Amgen Inc. | $16.85 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117321228 | CMS |
| Dexcom, Inc. | $25.30 | 04/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153297022 | CMS |
| Lilly USA, LLC | $23.89 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136151017 | CMS |
| Lilly USA, LLC | $19.24 | 04/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136160839 | CMS |
| Novo Nordisk Inc | $14.26 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096851171 | CMS |
| Novo Nordisk Inc | $16.93 | 09/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097817865 | CMS |
| PFIZER INC. | $26.37 | 12/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131503788 | CMS |
| Phadia US Inc. | $23.57 | 04/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1067578138 | CMS |
| Xeris Pharmaceuticals, Inc. | $16.80 | 12/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144593034 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.